000			02252 a2200577 4500
005			20250513045758.0
264		0	_c19950321
008			199503s 0 0 eng d
022			_a1077-9450
024	7		_a10.1097/00042560-199503010-00009 _2doi
040			_aNLM _beng _cNLM
100	1		_aGoldstein, G
245	0	0	_aSafety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial. _h[electronic resource]
260			_bJournal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association _cMar 1995
300			_a279-88 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650	0	4	_aAdult
650	0	4	_aCD4 Lymphocyte Count
650	0	4	_aDisease Progression
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Resistance, Microbial _xgenetics
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHIV _xdrug effects
650	0	4	_aHIV Core Protein p24 _xblood
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHumans
650	0	4	_aInjections, Subcutaneous
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPatient Compliance
650	0	4	_aPentamidine _xtherapeutic use
650	0	4	_aPneumonia, Pneumocystis _xprevention & control
650	0	4	_aPrognosis
650	0	4	_aProportional Hazards Models
650	0	4	_aThymopentin _xadministration & dosage
650	0	4	_aTrimethoprim, Sulfamethoxazole Drug Combination _xtherapeutic use
650	0	4	_aZidovudine _xtherapeutic use
700	1		_aConant, M A
700	1		_aBeall, G
700	1		_aGrossman, H A
700	1		_aGalpin, J E
700	1		_aBlick, G
700	1		_aCalabrese, L H
700	1		_aHirsch, R L
700	1		_aFisher, A
700	1		_aStampone, P
773	0		_tJournal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association _gvol. 8 _gno. 3 _gp. 279-88
856	4	0	_uhttps://doi.org/10.1097/00042560-199503010-00009 _zAvailable from publisher's website
999			_c7858476 _d7858476